https://v2.webnotes.in/tags/thematic/Recent content in Thematic on WebNotesHugoen-INTue, 19 May 2026 00:00:00 +0000https://v2.webnotes.in/thematic-funds-india/Tue, 19 May 2026 00:00:00 +0000https://v2.webnotes.in/thematic-funds-india/<p><strong>Thematic mutual funds</strong> are SEBI-defined equity schemes that invest in stocks across multiple sectors linked to a single investment theme rather than confining to one specific sector. Per the <a href="https://v2.webnotes.in/sebi-mf-categorisation-october-2017/">SEBI October 2017 categorisation</a> , thematic funds are paired with <a href="https://v2.webnotes.in/sectoral-thematic-mutual-fund/">sectoral funds</a> under the single SEBI category &ldquo;Sectoral / Thematic&rdquo; but operate on a broader investment universe than pure sectoral funds.</p> <p>For Indian retail investors, thematic funds offer concentrated exposure to specific investment themes (e.g., consumption growth, infrastructure spending, digital transformation, ESG, manufacturing) that the manager believes will outperform the broader market over a given timeframe. The category sits in the higher-risk, higher-potential-return spectrum of equity mutual funds.</p>https://v2.webnotes.in/pharma-healthcare-fund/Mon, 18 May 2026 00:00:00 +0000https://v2.webnotes.in/pharma-healthcare-fund/<p>A <strong>Pharma and Healthcare mutual fund</strong> is a thematic equity scheme that invests at least 80 per cent of its corpus in pharmaceutical, healthcare, and life-sciences companies. The category sits within the SEBI <a href="https://v2.webnotes.in/sectoral-thematic-mutual-fund/">sectoral and thematic</a> framework. Pharma/healthcare is a popular thematic category among Indian retail investors, reflecting India&rsquo;s position as a global pharma hub and the defensive characteristics of healthcare equity.</p> <p>For Indian retail investors, pharma/healthcare mutual funds offer:</p> <ul> <li><strong>Defensive equity exposure</strong>: Less cyclical than industrials, banking.</li> <li><strong>Export-oriented growth</strong>: Indian pharma&rsquo;s global export footprint.</li> <li><strong>Demographic tailwind</strong>: Aging populations driving healthcare demand.</li> <li><strong>Sectoral diversification</strong>: Pharma manufacturers + hospitals + diagnostics + medtech.</li> </ul> <h2 id="major-pharmahealthcare-funds">Major pharma/healthcare funds</h2> <ul> <li><strong>ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D.) Fund</strong>.</li> <li><strong>SBI Healthcare Opportunities Fund</strong>.</li> <li><strong>Nippon India Pharma Fund</strong>.</li> <li><strong>DSP Healthcare Fund</strong>.</li> <li><strong>Aditya Birla Sun Life Pharma and Healthcare Fund</strong>.</li> <li><strong>Mirae Asset Healthcare Fund</strong>.</li> <li><strong>Tata India Pharma and Healthcare Fund</strong>.</li> </ul> <h2 id="investment-universe">Investment universe</h2> <p>Pharma/healthcare funds invest across:</p>